Recent Sentinel Activity

This recent activity feed provides a list of the last 90 days of Sentinel activity across assessments, publications & presentations, projects, events, etc.

RSS Feed

URL	Title	Category	Date	Recent Activity
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/risk-cardiac-congenital-malformations-following-0	Risk of Cardiac Congenital Malformations Following Armodafinil or Modafinil Use: A Descriptive Analysis	Modular Programs	11/17/2020	Risk of Cardiac Congenital Malformations Following Armodafinil or Modafinil Use: A Descriptive Analysis Modular Programs 11/17/2020
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/risk-cardiac-congenital-malformations-following-armodafinil	Risk of Cardiac Congenital Malformations Following Armodafinil or Modafinil Use: A Propensity Score Matched Analysis	Modular Programs	11/17/2020	Risk of Cardiac Congenital Malformations Following Armodafinil or Modafinil Use: A Propensity Score Matched Analysis Modular Programs 11/17/2020
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/characterization-mothers-mother-infant-linkage-table	Characterization of Mothers in the Mother-Infant Linkage Table in the Sentinel Distributed Database: A Descriptive Analysis	Modular Programs	03/11/2021	Characterization of Mothers in the Mother-Infant Linkage Table in the Sentinel Distributed Database: A Descriptive Analysis Modular Programs 03/11/2021
https://www.sentinelinitiative.org/methods-data-tools/methods/representation-unstructured-data-across-common-data-models	Representation of Unstructured Data Across Common Data Models	Methods, Data, & Tools	07/14/2021	Representation of Unstructured Data Across Common Data Models Methods, Data, & Tools 07/14/2021
https://www.sentinelinitiative.org/methods-data-tools/methods/making-medicaid-data-more-accessible-through-common-data-models-and-fhir	Making Medicaid Data More Accessible Through Common Data Models and FHIR APIs	Methods, Data, & Tools	09/24/2021	Making Medicaid Data More Accessible Through Common Data Models and FHIR APIs Methods, Data, & Tools 09/24/2021
https://www.sentinelinitiative.org/engage-sentinel/quarterly-newsletter	Quarterly Newsletter	Spotlight	03/24/2022	Quarterly Newsletter Spotlight 03/24/2022
https://www.sentinelinitiative.org/methods-data-tools/methods/approaches-handling-partially-observed-confounder-data-electronic-health	Approaches to Handling Partially Observed Confounder Data From Electronic Health Records (EHR) In Non-randomized Studies of Medication Outcomes	Methods, Data, & Tools	06/01/2022	Approaches to Handling Partially Observed Confounder Data From Electronic Health Records (EHR) In Non-randomized Studies of Medication Outcomes Methods, Data, & Tools 06/01/2022
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/characterizing-pregnant-women-and-without-evidence-heart	Characterizing Pregnant Women With and Without Evidence of Heart Failure and Non-Pregnant Women With Heart Failure: A Propensity Score Matched Analysis	Analyses	06/21/2022	Characterizing Pregnant Women With and Without Evidence of Heart Failure and Non-Pregnant Women With Heart Failure: A Propensity Score Matched Analysis Analyses 06/21/2022
https://www.sentinelinitiative.org/news-events/publications-presentations/characterizing-infants-sentinel-distributed-database-mother	Characterizing Infants in the Sentinel Distributed Database Mother-Infant Linkage Table	Publications and Presentations	08/28/2022	Characterizing Infants in the Sentinel Distributed Database Mother-Infant Linkage Table Publications and Presentations 08/28/2022
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/utilization-ibrexafungerp-pregnant-patients-descriptive	Utilization of Ibrexafungerp in Pregnant Patients: A Descriptive Analysis in TriNetX	Analyses	10/31/2022	Utilization of Ibrexafungerp in Pregnant Patients: A Descriptive Analysis in TriNetX Analyses 10/31/2022
https://www.sentinelinitiative.org/methods-data-tools/methods/onboarding-commercial-electronic-health-record-ehr-data-partners	Onboarding of Commercial Electronic Health Record (EHR) Data Partners	Methods, Data, & Tools	11/01/2022	Onboarding of Commercial Electronic Health Record (EHR) Data Partners Methods, Data, & Tools 11/01/2022
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/outcome-monitoring-following-ozempic-use-patients-type-2	Outcome Monitoring Following Ozempic Use in Patients with Type 2 Diabetes: A Signal Identification Analysis	Analyses	11/10/2022	Outcome Monitoring Following Ozempic Use in Patients with Type 2 Diabetes: A Signal Identification Analysis Analyses 11/10/2022
https://www.sentinelinitiative.org/methods-data-tools/methods/inclusion-semi-structured-and-unstructured-electronic-health-record-ehr	Inclusion of Semi-Structured and Unstructured Electronic Health Record (EHR) Data in Confounding Adjustment and Outcome Ascertainment	Methods, Data, & Tools	12/09/2022	Inclusion of Semi-Structured and Unstructured Electronic Health Record (EHR) Data in Confounding Adjustment and Outcome Ascertainment Methods, Data, & Tools 12/09/2022
https://www.sentinelinitiative.org/news-events/meetings-workshops-trainings/2023-sentinel-innovation-and-methods-seminar-series	2023 Sentinel Innovation and Methods Seminar Series	Sentinel Initiative Events	01/01/2023	2023 Sentinel Innovation and Methods Seminar Series Sentinel Initiative Events 01/01/2023
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/cardiovascular-outcomes-following-percutaneous-transluminal	Cardiovascular Outcomes Following Percutaneous Transluminal Septal Myocardial Ablation (PTSMA) Procedures: A Descriptive Analysis	Analyses	02/09/2023	Cardiovascular Outcomes Following Percutaneous Transluminal Septal Myocardial Ablation (PTSMA) Procedures: A Descriptive Analysis Analyses 02/09/2023
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/cardiovascular-outcomes-following-percutaneous	Cardiovascular Outcomes Following Percutaneous Transluminal Septal Myocardial Ablation (PTSMA) Procedures: An Updated Descriptive Analysis	Analyses	02/09/2023	Cardiovascular Outcomes Following Percutaneous Transluminal Septal Myocardial Ablation (PTSMA) Procedures: An Updated Descriptive Analysis Analyses 02/09/2023
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/congenital-malformations-observed-mother-s-or-linked-infant	Congenital Malformations Observed in the Mother’s or Linked Infant’s Records Following Fingolimod Use During Pregnancy: A Descriptive Analysis	Analyses	03/03/2023	Congenital Malformations Observed in the Mother’s or Linked Infant’s Records Following Fingolimod Use During Pregnancy: A Descriptive Analysis Analyses 03/03/2023
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/congenital-malformations-observed-mother-s-records-following	Congenital Malformations Observed in the Mother’s Records Following Fingolimod Use During Pregnancy: A Descriptive Analysis	Analyses	03/03/2023	Congenital Malformations Observed in the Mother’s Records Following Fingolimod Use During Pregnancy: A Descriptive Analysis Analyses 03/03/2023
https://www.sentinelinitiative.org/news-events/meetings-workshops-trainings/healthverity-being-evaluated-fda-s-sentinel-initiative	HealthVerity Being Evaluated for FDA’s Sentinel Initiative	Sentinel Initiative Events	03/21/2023	HealthVerity Being Evaluated for FDA’s Sentinel Initiative Sentinel Initiative Events 03/21/2023
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/utilization-select-products-migraine-treatment-and	Utilization of Select Products for Migraine Treatment and Prevention: A Descriptive Analysis	Analyses	03/22/2023	Utilization of Select Products for Migraine Treatment and Prevention: A Descriptive Analysis Analyses 03/22/2023
https://www.sentinelinitiative.org/news-events/meetings-workshops-trainings/cerner-enviza-collaborates-fda-develop-innovative-ai-tools	Cerner Enviza Collaborates with FDA to Develop Innovative AI Tools for Drug Safety and Real-World Evidence Studies	Sentinel Initiative Events	04/06/2023	Cerner Enviza Collaborates with FDA to Develop Innovative AI Tools for Drug Safety and Real-World Evidence Studies Sentinel Initiative Events 04/06/2023
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/brand-generic-switching-patterns-among-advair-diskus-users	Brand to Generic Switching Patterns Among Advair Diskus Users with Asthma or Chronic Obstructive Pulmonary Disease (COPD): A Descriptive Analysis	Analyses	05/01/2023	Brand to Generic Switching Patterns Among Advair Diskus Users with Asthma or Chronic Obstructive Pulmonary Disease (COPD): A Descriptive Analysis Analyses 05/01/2023
https://www.sentinelinitiative.org/news-events/publications-presentations/characterizing-missing-data-processes-ehr-data	Characterizing Missing Data Processes in EHR Data	Publications and Presentations	05/10/2023	Characterizing Missing Data Processes in EHR Data Publications and Presentations 05/10/2023
https://www.sentinelinitiative.org/studies/drugs/zarxio-filgrastim-sndz	Zarxio (Filgrastim-sndz) & Signal Identification	Studies	06/01/2023	Zarxio (Filgrastim-sndz) & Signal Identification Studies 06/01/2023
https://www.sentinelinitiative.org/news-events/publications-presentations/r-package-perform-routine-structural-missing-data	An R Package to Perform Routine Structural Missing Data Investigations in Real-World Data	Publications and Presentations	06/06/2023	An R Package to Perform Routine Structural Missing Data Investigations in Real-World Data Publications and Presentations 06/06/2023
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/mortality-following-long-acting-injectable-antipsychotics	Mortality Following Long-Acting Injectable Antipsychotics Use in Patients with Dementia: An Inverse Probability of Treatment Weighting Analysis	Analyses	06/08/2023	Mortality Following Long-Acting Injectable Antipsychotics Use in Patients with Dementia: An Inverse Probability of Treatment Weighting Analysis Analyses 06/08/2023
https://www.sentinelinitiative.org/news-events/publications-presentations/signal-detection-and-refinement-activities-within-fda-s-0	Signal Detection and Refinement Activities within FDA’s Sentinel System	Publications and Presentations	06/28/2023	Signal Detection and Refinement Activities within FDA’s Sentinel System Publications and Presentations 06/28/2023
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/characterization-cannabis-derived-product-users-trinetx-four	Characterization of Cannabis-Derived Product Users in TriNetX: Four Descriptive Analyses	Analyses	07/19/2023	Characterization of Cannabis-Derived Product Users in TriNetX: Four Descriptive Analyses Analyses 07/19/2023
https://www.sentinelinitiative.org/studies/drugs/individual-drug-analyses/bevacizumab-and-other-cancer-medication-use-pregnant	Bevacizumab and Other Cancer Medication Use in Pregnant Patients: A Descriptive Analysis	Analyses	08/04/2023	Bevacizumab and Other Cancer Medication Use in Pregnant Patients: A Descriptive Analysis Analyses 08/04/2023
https://www.sentinelinitiative.org/news-events/publications-presentations/introducing-colab-evolution-us-canada-international	Introducing CoLab: The Evolution of US-Canada International Collaboration on Drug Safety and Effectiveness	Publications and Presentations	08/25/2023	Introducing CoLab: The Evolution of US-Canada International Collaboration on Drug Safety and Effectiveness Publications and Presentations 08/25/2023
https://www.sentinelinitiative.org/news-events/publications-presentations/characterizing-medication-use-patterns-among-pregnant-and	Characterizing Medication Use Patterns Among Pregnant and Non-Pregnant Patients with COVID-19 in the Sentinel System	Publications and Presentations	08/25/2023	Characterizing Medication Use Patterns Among Pregnant and Non-Pregnant Patients with COVID-19 in the Sentinel System Publications and Presentations 08/25/2023
https://www.sentinelinitiative.org/news-events/publications-presentations/utilization-beta-blockers-among-pediatric-population-united	Utilization of Beta-blockers Among the Pediatric Population in the United States: A Study in the FDA’s Sentinel System from 2008 to 2022	Publications and Presentations	08/25/2023	Utilization of Beta-blockers Among the Pediatric Population in the United States: A Study in the FDA’s Sentinel System from 2008 to 2022 Publications and Presentations 08/25/2023
https://www.sentinelinitiative.org/news-events/publications-presentations/association-between-race-and-covid-19-outcomes-united-states	Association Between Race and COVID-19 Outcomes in the United States (2020-2021)	Publications and Presentations	08/25/2023	Association Between Race and COVID-19 Outcomes in the United States (2020-2021) Publications and Presentations 08/25/2023
https://www.sentinelinitiative.org/news-events/publications-presentations/high-dose-dexamethasone-covid-19-not-common-large-us	High Dose Dexamethasone for COVID-19 Not Common in a Large US Hospital Network	Publications and Presentations	08/25/2023	High Dose Dexamethasone for COVID-19 Not Common in a Large US Hospital Network Publications and Presentations 08/25/2023
https://www.sentinelinitiative.org/news-events/publications-presentations/racial-and-ethnic-differences-treatment-hospitalized-and	Racial and Ethnic Differences in Treatment of Hospitalized and Critical COVID-19, January 2021 - April 2022	Publications and Presentations	08/25/2023	Racial and Ethnic Differences in Treatment of Hospitalized and Critical COVID-19, January 2021 - April 2022 Publications and Presentations 08/25/2023
https://www.sentinelinitiative.org/news-events/publications-presentations/variation-mother-infant-linkage-rates-jurisdiction-us	Variation in Mother-Infant Linkage Rates by Jurisdiction in U.S. Medicaid Data	Publications and Presentations	08/26/2023	Variation in Mother-Infant Linkage Rates by Jurisdiction in U.S. Medicaid Data Publications and Presentations 08/26/2023
https://www.sentinelinitiative.org/news-events/publications-presentations/diversifying-fda-s-sentinel-system-rigorous-quality	Diversifying the FDA’s Sentinel System with Rigorous Quality Inclusion Rules for the U.S. Medicaid Population	Publications and Presentations	08/26/2023	Diversifying the FDA’s Sentinel System with Rigorous Quality Inclusion Rules for the U.S. Medicaid Population Publications and Presentations 08/26/2023
https://www.sentinelinitiative.org/news-events/publications-presentations/nlp-detection-mortality-information-publicly-available-data	NLP Detection of Mortality Information from Publicly Available Data Using Deep Learning Modeling	Publications and Presentations	08/26/2023	NLP Detection of Mortality Information from Publicly Available Data Using Deep Learning Modeling Publications and Presentations 08/26/2023
https://www.sentinelinitiative.org/news-events/publications-presentations/utilization-gonadotropin-releasing-hormone-agonist-products	Utilization of Gonadotropin-Releasing Hormone Agonist Products in Adolescents	Publications and Presentations	08/26/2023	Utilization of Gonadotropin-Releasing Hormone Agonist Products in Adolescents Publications and Presentations 08/26/2023
https://www.sentinelinitiative.org/news-events/publications-presentations/hospitalized-arterial-and-venous-thrombotic-events-patients	Hospitalized Arterial and Venous Thrombotic Events in Patients Diagnosed in the Ambulatory Setting with COVID-19 Compared to Influenza	Publications and Presentations	08/27/2023	Hospitalized Arterial and Venous Thrombotic Events in Patients Diagnosed in the Ambulatory Setting with COVID-19 Compared to Influenza Publications and Presentations 08/27/2023